- CORRESPONDENCE
Clinical trials: Japan’s opt-out policy raises risks of adverse drug responses
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 626, 261 (2024)
doi: https://doi.org/10.1038/d41586-024-00301-7
Competing Interests
A.O. received personal fees from Medical Network Systems Inc. and Kyowa Kirin Co. Ltd outside the submitted work. T.T. received personal fees from Medical Network Systems Inc. and Bionics Co. Ltd, outside the submitted work.